Toll-like receptor 3 signalling up-regulates expression of the HIV co-receptor G-protein coupled receptor 15 on human CD4+ T cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Kiene, Miriam ^a,b   Rethi, Bence ^b   Jansson, Marianne ^d   Dillon, Stephanie ^e   Lee, Eric ^e   Lantto, Rebecka ^b   Wilson, Cara ^e   Pöhlmann, Stefan ^c   Chiodi, Francesca ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GERMAN PRIMATE CENTER   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 15; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; CD19 ANTIGEN; GPR15 PROTEIN, HUMAN; RECEPTOR; TLR3 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL HOMING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; INTESTINE; LYMPH NODE; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; BIOPSY; CD8+ T LYMPHOCYTE; CELL SEPARATION; COLON; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; VIROLOGY;

ADULT; ANTIGENS, CD19; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; COLON; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; UP-REGULATION;

EID: 84895891496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088195     Document Type: Article

References (65)

1. Tilton JC and Doms RW (2010) Entry inhibitors in the treatment of HIV-1 infection. Antiviral research 85: 91-100.
2. Frange P, Meyer L, Ghosn J, Deveau C, Goujard C, et al. (2013) Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infection. Clin Microbiol Infect 19: E252-255.
3. Huang W, Toma J, Stawiski E, Fransen S, Wrin T, et al. (2009) Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS research and human retroviruses 25: 795-802.
4. Fenyo EM, Esbjornsson J, Medstrand P and Jansson M (2011) Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance. Journal of internal medicine 270: 520-531.
5. Schuitemaker H, van 't Wout AB and Lusso P (2011) Clinical significance of HIV-1 coreceptor usage. J Transl Med 9 Suppl 1: S5.
6. Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, et al. (2005) CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J Virol 79: 1686-1700. (Pubitemid 40459115)
7. Elliott ST, Riddick NE, Francella N, Paiardini M, Vanderford TH, et al. (2012) Cloning and analysis of sooty mangabey alternative coreceptors that support simian immunodeficiency virus SIVsmm entry independently of CCR5. J Virol 86: 898-908.
8. Farzan M, Choe H, Martin K, Marcon L, Hofmann W, et al. (1997) Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. The Journal of experimental medicine 186: 405-411. (Pubitemid 27332898)
9. Morner A, Bjorndal A, Albert J, Kewalramani VN, Littman DR, et al. (1999) Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 73: 2343-2349. (Pubitemid 29098139)
10. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, et al. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71: 8999-9007. (Pubitemid 27492339)
11. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, et al. (1997) Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71: 7478-7487. (Pubitemid 27391688)
12. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666. (Pubitemid 26197679)
13. Pohlmann S, Krumbiegel M and Kirchhoff F (1999) Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. The Journal of general virology 80 (Pt 5): 1241-1251. (Pubitemid 29213812)
14. Zhang YJ, Zhang L, Ketas T, Korber BT and Moore JP (2001) HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry. AIDS research and human retroviruses 17: 217-227. (Pubitemid 32113569)
15. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, et al. (2000) Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood 96: 41-49. (Pubitemid 30456448)
16. Willey RL, Bonifacino JS, Potts BJ, Martin MA and Klausner RD (1988) Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proceedings of the National Academy of Sciences of the United States of America 85: 9580-9584. (Pubitemid 19027171)
17. Poveda E, Paredes R, Moreno S, Alcami J, Cordoba J, et al. (2012) Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists. AIDS reviews 14: 208-217.
18. Cilliers T, Willey S, Sullivan WM, Patience T, Pugach P, et al. (2005) Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology 339: 136-144. (Pubitemid 41096070)
19. Edinger AL, Amedee A, Miller K, Doranz BJ, Endres M, et al. (1997) Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proceedings of the National Academy of Sciences of the United States of America 94: 4005-4010. (Pubitemid 27180489)
20. Zhang L, He T, Huang Y, Chen Z, Guo Y, et al. (1998) Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol 72: 9307-9312. (Pubitemid 28471879)
21. Pohlmann S, Stolte N, Munch J, Ten Haaft P, Heeney JL, et al. (1999) Coreceptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. The Journal of infectious diseases 180: 1494-1502. (Pubitemid 29506450)
22. Jiang C, Parrish NF, Wilen CB, Li H, Chen Y, et al. (2011) Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. J Virol 85: 10669-10681.
23. Kiene M, Marzi A, Urbanczyk A, Bertram S, Fisch T, et al. (2012) The role of the alternative coreceptor GPR15 in SIV tropism for human cells. Virology 433: 73-84.
24. Kim SV, Xiang WV, Kwak C, Yang Y, Lin XW, et al. (2013) GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 340: 1456-1459.
25. Tomchuck SL, Henkle SL, Coffelt SB and Betancourt AM (2012) Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. PloS one 7: e39592.
26. Chung JJ, Okamoto Y, Coblitz B, Li M, Qiu Y, et al. (2009) PI3K/Akt signalling-mediated protein surface expression sensed by 14-3-3 interacting motif. The FEBS journal 276: 5547-5558.
27. Sarkar SN, Smith HL, Rowe TM and Sen GC (2003) Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain. The Journal of biological chemistry 278: 4393-4396. (Pubitemid 36800930)
28. Lusso P, Cocchi F, Balotta C, Markham PD, Louie A, et al. (1995) Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol 69: 3712-3720.
29. Dolganiuc A, Garcia C, Kodys K and Szabo G (2006) Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 12: 1198-1204.
30. Hammond T, Lee S, Watson MW, Flexman JP, Cheng W, et al. (2010) Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus. Cellular immunology 264: 150-155.
31. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531-4537. (Pubitemid 34441357)
32. Kawai T and Akira S (2006) TLR signaling. Cell death and differentiation 13: 816-825.
33. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371. (Pubitemid 44924494)
34. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. The Journal of experimental medicine 200: 749-759. (Pubitemid 39299461)
35. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77: 11708-11717. (Pubitemid 37271669)
36. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, et al. (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434: 1148-1152. (Pubitemid 40663495)
37. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097. (Pubitemid 40663481)
38. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, et al. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431. (Pubitemid 28208163)
39. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, et al. (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nature immunology 9: 301-309. (Pubitemid 351267327)
40. Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, et al. (2001) Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. The Journal of infectious diseases 183: 555-562. (Pubitemid 32147511)
41. Groot F, van Capel TM, Schuitemaker J, Berkhout B and de Jong EC (2006) Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 3: 52.
42. Yang X, Jiao YM, Wang R, Ji YX, Zhang HW, et al. (2012) High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression. PloS one 7: e49526.
43. Mackay CR, Marston WL and Dudler L (1990) Naive and memory T cells show distinct pathways of lymphocyte recirculation. The Journal of experimental medicine 171: 801-817. (Pubitemid 20088983)
44. Sallusto F, Geginat J and Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annual review of immunology 22: 745-763. (Pubitemid 38680440)
45. Murooka TT, Deruaz M, Marangoni F, Vrbanac VD, Seung E, et al. (2012) HIV-infected T cells are migratory vehicles for viral dissemination. Nature 490: 283-287.
46. Alexopoulou L, Holt AC, Medzhitov R and Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738. (Pubitemid 33009951)
47. Weber F, Wagner V, Rasmussen SB, Hartmann R and Paludan SR (2006) Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80: 5059-5064.
48. Marshall-Clarke S, Downes JE, Haga IR, Bowie AG, Borrow P, et al. (2007) Polyinosinic acid is a ligand for toll-like receptor 3. The Journal of biological chemistry 282: 24759-24766. (Pubitemid 47347556)
49. Sanghavi SK and Reinhart TA (2005) Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J Immunol 175: 5314-5323. (Pubitemid 41456417)
50. Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, et al. (2008) Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. Aids 22: 685-694. (Pubitemid 351450636)
51. Pierson T, McArthur J and Siliciano RF (2000) Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annual review of immunology 18: 665-708. (Pubitemid 30365394)
52. Funami K, Sasai M, Ohba Y, Oshiumi H, Seya T, et al. (2007) Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA. J Immunol 179: 6867-6872.
53. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, et al. (2003) Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171: 3154-3162. (Pubitemid 37093540)
54. Haase AT (2010) Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464: 217-223.
55. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, et al. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384: 179-183. (Pubitemid 26386475)
56. Simone R, Floriani A and Saverino D (2009) Stimulation of human CD4(+) T lymphocytes via TLR3, TLR5 and TLR7/8 up-regulates expression of costimulatory and modulates proliferation. Open Microbiol J 3: 1-8.
57. Mansson A, Adner M and Cardell LO (2006) Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 7: 36.
58. Dasari P, Nicholson IC, Hodge G, Dandie GW and Zola H (2005) Expression of toll-like receptors on B lymphocytes. Cellular immunology 236: 140-145. (Pubitemid 41771098)
59. Xu W, Santini PA, Matthews AJ, Chiu A, Plebani A, et al. (2008) Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J Immunol 181: 276-287.
60. Clayton F, Kotler DP, Kuwada SK, Morgan T, Stepan C, et al. (2001) Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. The American journal of pathology 159: 1933-1939. (Pubitemid 33062535)
61. Li Q, Estes JD, Duan L, Jessurun J, Pambuccian S, et al. (2008) Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. The Journal of infectious diseases 197: 420-429. (Pubitemid 351263424)
62. Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, et al. (1996) Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proceedings of the National Academy of Sciences of the United States of America 93: 15382-15387. (Pubitemid 27009609)
63. Dillon SM, Rogers LM, Howe R, Hostetler LA, Buhrman J, et al. (2010) Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. J Immunol 184: 6612-6621.
64. Howe R, Dillon S, Rogers L, McCarter M, Kelly C, et al. (2009) Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin Immunol 131: 317-332.
65. Dillon SM, Manuzak JA, Leone AK, Lee EJ, Rogers LM, et al. (2012) HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli. J Immunol 189: 885-896.